As a consequence, considering the important roles of BRCA1 and BRCA2 mutations in development of breast cancer, strategies in supplying the wild type BRCA1 and BRCA2 gene could be promising as a therapeutic option. The gene discussed is BRCA1; the disease is breast cancer.